Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
about
MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenibBiomarker-based MicroRNA Therapeutic Strategies for Hepatocellular CarcinomaThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateInsufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFAA novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma.Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities.Prognostic significance of Cbx4 expression and its beneficial effect for transarterial chemoembolization in hepatocellular carcinoma.URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implicationsTransarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study.Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma.Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron ContentSuperparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude miceNovel inhibitors in development for hepatocellular carcinoma.Chemical inhibition reveals differential requirements of signaling pathways in krasV12- and Myc-induced liver tumors in transgenic zebrafish.Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma.Potential role for anti-angiogenic therapy in abdominal aortic aneurysms.Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea.Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients.Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy.Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.Identification of β-glucosidase 1 as a biomarker and its high expression in hepatocellular carcinoma is associated with resistance to chemotherapy drugs.Human collagen XV is a prominent histopathological component of sinusoidal capillarization in hepatocellular carcinogenesis.Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma.Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib.Application of 128 slice 4D CT whole liver perfusion imaging in hepatic tumor.Roles of Tumor Microenvironment in Hepatocelluar Carcinoma.Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models.The Expanding Role of Systemic Therapy in the Management of Hepatocellular CarcinomaDevelopment for High-AccuracyIn VitroAssay of Vascular Endothelial Growth Factor Using Nanomagnetically Labeled Immunoassay
P2860
Q24655048-09A08699-29FD-4E21-9014-6B63CB44CF33Q26782003-46289475-7B74-4452-AF98-46C75A29C95CQ27003050-2B67FD9E-7C01-4B3A-B42F-45CE060E5358Q28483727-3DDDABC6-DC98-44D6-BE6D-3A07DF9B2FDFQ30547848-5E643CEE-21C4-4337-A2E4-15E2D0FF0E3FQ34114265-BE0698CD-0C07-493C-A1CF-EF9C63358BA9Q34131801-48384F7F-DCD7-4938-B79C-CDAC4AAE4FB1Q34221867-EC8A1A1A-F37F-4A64-AC5B-68B0C8170728Q34630557-21EB8536-B17E-46CA-8C26-99C0C9761908Q34644926-20D5B38F-65C5-4E07-A650-049D70CFD8EDQ35274662-CAFAB0C5-1220-49C0-8809-7ECA6D770AB5Q35623604-ABA91CE5-2B31-4E13-B71D-9BB824B01F8FQ35759606-51EA41B7-CF2C-4F65-A4B9-09CC68C61A1CQ35797957-BEC7783B-61DB-455B-967D-6DA168027854Q36725301-5093B0B5-7A92-45B8-8B5F-CDBB11CA9A49Q37378982-798C91DB-AF6E-4D01-9FA0-81F7C8006FC4Q37523542-6513464A-F3E0-4F23-ACD8-C1B467145483Q37609755-D6D77BBF-F5F7-4E92-8ADB-E16D2E5786DAQ37725994-CC2BA218-A183-4437-B8E4-866CC9036204Q37738003-D8FB3399-8210-4BDA-A9DA-20547C0CFB97Q37821305-A4FB1B82-FA0A-4A19-B84A-35304580759AQ38106736-C0AD442C-9744-4EF7-9A1C-E7A84EA29F3EQ38158226-C8ACA041-D8E0-429E-A5B9-20820993986CQ38862725-AAE09C77-5BFC-4A32-B602-8D96C3D5E8DFQ39143305-BEA1B736-6C18-4BE0-8CB0-A2C5A25EEE9EQ39701660-47222B64-9800-402E-A16F-3E92232D6FD8Q40019761-7D620BB2-1BE7-45F8-9EDF-665B8D5EBD46Q41465593-A3782322-EA3E-4428-9612-D89E5241AAC5Q41637262-A385EC84-F1D3-4ECF-9FAC-10C17DAC2C7BQ41910456-BCFBADCE-923E-4AFA-8BB4-1AB985931D44Q41917123-05766B53-C7EE-4E08-BC77-C3596CE13662Q45355137-23F67627-3E2F-4A7F-BC10-9F94D0830543Q47132613-0A653E2A-4977-46C4-9E25-74CAA0D56E42Q52345488-9CC1C020-F391-4DFC-BF1A-684582607FC6Q54111915-7AA7C2EE-DB7E-404E-9F5A-D4DDB88E7F4DQ58797003-49B36D3F-3C9F-452F-BB36-C6C693E99509Q59017448-CEA9BBC5-103D-475B-AFDF-F81CF8B157E1
P2860
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
@en
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
@nl
type
label
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
@en
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
@nl
prefLabel
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
@en
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
@nl
P2860
P356
P1476
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.
@en
P2093
Andrew X Zhu
Richard S Finn
P2860
P304
P356
10.1586/ERA.09.6
P577
2009-04-01T00:00:00Z